- Home
- / Jacobson Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jacobson Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.6
2024-10-29
Market Capitalization
$1.2 B
2024-10-29
Revenue
$1.6 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| HKD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.7B | 1.8B | 1.5B | 1.6B | 1.8B | 1.7B | 1.6B |
| Cost of goods sold | 816.3M | 897.9M | 901.9M | 704.6M | 775.8M | 852.8M | 801.0M | 737.9M |
| Gross profit | 734.8M | 812.7M | 879.1M | 849.0M | 845.6M | 998.2M | 938.4M | 903.0M |
| Gross profit margin, % | 47.4% | 47.7% | 50.0% | 58.1% | 53.0% | 55.9% | 54.9% | 57.3% |
| Operating expense total | 342.2M | 353.3M | 394.6M | 410.6M | 406.8M | 429.2M | 402.2M | 326.5M |
| Depreciation and amortization | 112.4M | 114.3M | 170.8M | 191.7M | 192.6M | 184.5M | 156.5M | 143.9M |
| EBITDA | 392.5M | 464.0M | 485.1M | 432.9M | 435.0M | 565.4M | 535.8M | 577.0M |
| EBITDA margin, % | 25.3% | 27.2% | 27.6% | 29.6% | 27.3% | 31.7% | 31.3% | 36.6% |
| EBIT | 280.1M | 354.8M | 313.9M | 249.7M | 242.7M | 386.3M | 380.8M | 429.9M |
| EBIT margin, % | 18.1% | 20.8% | 17.9% | 17.1% | 15.2% | 21.6% | 22.3% | 27.3% |
| Interest income | 3.9M | 4.7M | 5.8M | 2.1M | 1.9M | 18.1M | 24.0M | 14.7M |
| Interest expense | 46.0M | 66.2M | 55.6M | 30.1M | 25.7M | 67.4M | 82.0M | 41.4M |
| Pre tax profit | 251.2M | 315.1M | 265.6M | 220.6M | 231.4M | 339.8M | 347.2M | 373.6M |
| Income tax expense | 46.3M | 56.4M | 46.5M | 34.2M | 43.7M | 56.5M | 56.5M | 72.8M |
| Net Income | 204.9M | 258.7M | 219.1M | 186.3M | 187.7M | 283.2M | 290.8M | 300.8M |